Neo, your view on orbis positioning re oncology has some merit IMO.
Could Orbis have achieved a split without driving the share price down? I can't see why not but I'm not much of a market watcher (more of a biotech 'value' investor).
the split I get (perhaps because I like it) but how this is connected to the share price drop when their position is still (proportionally) the same?
Happy for someone to educate me
1-2 mill per month, page-54
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable